Multiple Dose, Steady State-Partial reference replicate [Design Issues]

posted by ElMaestro  – Denmark, 2018-07-13 13:42 (1201 d 22:42 ago) – Posting: # 19047
Views: 3,331

Hi arl_stat,

» Please help in understanding whether it is possible to conduct “An open-label, randomized, Multiple Dose, Steady State, two treatments, three periods, three sequence, three way, Reference Replicated crossover bioequivalence study” for USFDA Submission?

Yes to everything except (conditionally) the term 'three way' in the context of your post.

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,758 posts in 4,550 threads, 1,545 registered users;
online 4 (1 registered, 3 guests [including 3 identified bots]).
Forum time: Wednesday 12:24 CEST (Europe/Vienna)

There ain’t no rules around here!
We’re trying to accomplish something!    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5